Recor Medical, Inc., and its parent company, Otsuka Medical Devices Co., Ltd., have announced the first commercial uses of the Paradise Ultrasound Renal Denervation (uRDN) system in the United States. This system, recently approved by the FDA, marks a significant advancement in hypertension treatment. First-of-its-Kind Technology for Hypertension The Paradise system is a novel ultrasound-based […]
The U.S. Food and Drug Administration (FDA) has granted approval to Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., for the Paradise Ultrasound Renal Denervation (RDN) system. This groundbreaking technology presents a new adjunctive option for the treatment of patients whose hypertension is not adequately controlled by traditional means. A New […]
